NDC 0904-7253-35 - Dabigatran Etexilate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0904-7253
- Requested NDC
- 0904-7253-35
- Package NDCs from labels
- 0904-7253-35, 0904-7253-04, 0904-7253-68
- Manufacturer
- Major Pharmaceuticals | Alkem Laboratories Limited
- Effective date
- 2025-06-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dabigatran Etexilate - Major Pharmaceuticals | Alkem Laboratories Limited | Major Pharmaceuticals | Alkem Laboratories Limited | 2025-06-12 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7253-04 | Dabigatran Etexilate | 3 in 1 CARTON | CAPSULE, COATED PELLETS | 3 | 2 | |
| 0904-7253-35 | Dabigatran Etexilate | 10 in 1 BLISTER PACK | CAPSULE, COATED PELLETS | 10 | 2 | |
| 0904-7253-68 | Dabigatran Etexilate | 6 in 1 CARTON | CAPSULE, COATED PELLETS | 6 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7253-04 | EA - Each | 0904-7253 | b5410e85-ccc2-4a3b-add3-7ae457359e35 | 1 | 2025-05-14 |
| 0904-7253-35 | EA - Each | 0904-7253 | e9fe4203-0a1f-4844-9a60-5fe2c007f40d | 1 | 2025-05-14 |
| 0904-7253-68 | EA - Each | 0904-7253 | b8e42253-9fcb-4b5e-872e-6258a83d9eca | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GR BB SPF 25 | OCTINOXATE, OXYBENZONE, TITANIUM DIOXIDE | ERKUL KOZMETIK SANAYI VE TICARET ANONIM SIRKETI | 3b22579b-21ce-4b96-bd24-774ce35bf6f7 | 2025-08-06 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 08W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 498bf941-67f2-41d5-a039-9f827b68297e | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 10N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 54e390bd-b84a-4c43-986e-74923e34689d | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 09C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 897024cd-576e-4a8e-8daa-92dc3bb4b3a5 | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 11W Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 303967d1-9df8-4a8e-a264-6b0d8fdbf2a8 | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 12N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 26062cd7-3817-46c7-b65f-92cd57eca5dd | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 13C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 448a24a3-91ef-4530-828c-e77d8aae7f0b | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 02C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 09f9e59b-6f71-4d42-9b5d-275f756d985b | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| DABIGATRAN ETEXILATE | DABIGATRAN ETEXILATE | Aurobindo Pharma Limited | 5b196b1f-408e-4615-b980-9f822adff835 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 1723476 1037045 1037179 SC7NUW5IIT |
| Dabigatran Etexilate | DABIGATRAN ETEXILATE | Camber Pharmaceuticals, Inc. | 3c24e235-218b-438e-9456-42c18ff01913 | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | 1723476 1037045 1037179 SC7NUW5IIT |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | PHOENIX RX LLC | 3b2bf501-fd81-6ffa-e063-6394a90afe42 | 2025-07-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | PHOENIX RX LLC | 3b2cf6fd-72cb-fa53-e063-6394a90a674a | 2025-07-30 | Warnings, Adverse reactions | 8MDF5V39QO |
| Dabigatran Etexilate | DABIGATRAN ETEXILATE | Mylan Pharmaceuticals Inc. | baafb5be-ffe6-4755-a7ab-817b3c9b222d | 2025-07-30 | Boxed warning, Warnings, Adverse reactions | 1037045 1037179 SC7NUW5IIT |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.